EP3405452A1 - Verfahren zur herstellung von methioninanaloga - Google Patents
Verfahren zur herstellung von methioninanalogaInfo
- Publication number
- EP3405452A1 EP3405452A1 EP17706536.4A EP17706536A EP3405452A1 EP 3405452 A1 EP3405452 A1 EP 3405452A1 EP 17706536 A EP17706536 A EP 17706536A EP 3405452 A1 EP3405452 A1 EP 3405452A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- alkyl group
- group
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/02—Thiols having mercapto groups bound to acyclic carbon atoms
- C07C321/04—Thiols having mercapto groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/04—Sodium compounds
Definitions
- the present invention relates to a process for preparing analogs of methionine, as well as to the selenium derivatives of methionine analogs, from abundant and accessible compounds derived from biomass.
- Methionine and its analogs such as 2-hydroxy-4-methylthiobutanoic acid (HMTBA) and 2-oxo-4-methylthiobutane acid (KMB), as well as salts, chelates, especially metal chelates (from Zn, Ca, M n, Mg, Cu, Na ...) and esters of these acids, such as isopropyl and tert-butyl esters of H MTBA, are widely used in animal nutrition.
- the selenium derivatives of methionine and its hydroxyanalogues are also constituents of major interests in animal nutrition.
- this process makes it possible to prepare a compound or one of its salts, said compound corresponding to formula I,
- R 1 represents H or a C1-C6 alkyl group
- R 2 represents H, a C 1 -C 6 alkyl group, or an alkylaryl group
- R 3 is CH 2 SR 4 or CH 2 SeR 4 with R 4 is H or an alkyl group
- R 1 , R 2 and X are as defined above;
- R 5 represents H or COOR 6 with R 6 represents H or a C 1 -C 6 alkyl group.
- R 7 with R 7 represents H, a C 1 -C 6 alkyl group or an acyl group of formula CO-R 4 with R 4 as defined above; SR 4 or SeR 4 with R 4 as defined above; or NR 8 R 9 , with R 8 and R 9 , which may be identical or different, represent, each or together, a C 1 -C 6 alkyl group, or an alkylaryl group;
- Z which is the same or different from Y, represents OR 10 with R 10 represents H; a C 1 -C 6 alkyl group, or CO-R 4 with R 4 as defined above; a group N (COR 4 ) (COR 4 ), cyclic or acyclic, with R 4 as defined above; or a group NR 1: L R 12 , with R 11 and R 12 , which are identical or different, represent, each or together, a C 1 -C 6 alkyl group or an alkylaryl group;
- reaction of the compound (IV) with R 4 SH or one of its salts, or R 4 SeH or one of its salts, with R 4 according to the preceding definition, already present in the reaction medium or added during the process may lead to a compound having the structure (V) F ⁇ OOC-AMBKHF ⁇ -CHZZ (V)
- A represents OH; HN-R 'where R' is H or a C1-C6 alkyl group; or HN-OR "where R” is H, a C1-C6 alkyl group, or an alkylaryl group; and
- B represents SR 4 or SeR 4 with R 4 as defined above.
- alkyl denotes a monovalent hydrocarbon radical linear or branched having 1 to 20 carbon atoms, preferably 1 to 6 carbon atoms, such as methyl ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, neopentyl, ⁇ -hexyl or a monovalent cyclic hydrocarbon radical containing from 3 to 20 carbon atoms, advantageously from 3 to 6 carbon atoms, such as cyclopropyl, cyclohexyl.
- alkylaryl group is meant an aryl group comprising from 6 to 20 carbon atoms, said aryl group being substituted by at least one alkyl group as defined above.
- a first route preferably consists in reacting a compound (II) with formaldehyde or paraformaldehyde, in hydrated form or otherwise, in a basic medium and in the presence of MeSH or of one of its salts, such as sodium salts. , potassium or calcium methylmercaptan.
- a second route comprises reacting a compound (II) with a compound (III), said compound (III) being chosen from 1 - [(methylsulfanyl) methyl] - piperidine, 1 - [(methylsulfanyl) methyl] pyrrolidine and 1 - [(methylsulfanyl) methyl] diethylamine.
- This second route leads to an intermediate compound that can be isolated or not, which is an object of the present invention.
- This compound has the following formula (V):
- R 1 represents H or a C 1 -C 6 alkyl group
- R 2 represents H, a C 1 -C 6 alkyl group, or an alkylaryl group
- A represents OH; HN-R 'where R' is H or a C1-C6 alkyl group; or HN-OR “or R” represents H or a C1-C6 alkyl group or an alkylaryl group;
- B is SR 4 or SeR 4 with R 4 is H or C 1 -C 6 alkyl
- Z is OR with R is H; a C1-C6 alkyl group; a CO-R 4 group with R 4 represents H or a C 1 -C 6 alkyl group; a group N (COR 4 ) (COR 4 ), cyclic or acyclic, with R 4 as defined above; or NR 1: L R 12 , with R 11 and R 12 , identical or different, represent, each or together, a C 1 -C 6 alkyl group, or an alkylaryl group.
- the second route advantageously involves oxaloacetic acid or an ester thereof, that is to say a compound of formula (II) in which X represents 0, R 2 represents H and R 5 represents C0 2 R 6 with R 6 is H or C1-C6 alkyl, with a compound of formula (III) type CH 2 (Y) (Z) wherein Y and Z respectively represent the group SCH 3 and the group NR 1: L R 12 as defined above; preferably the NR 1 group : L R 12 represents the piperidinyl group.
- the invention therefore also relates to the compound of formula (V) in which A represents OH, B represents SCH 3 , R 2 represents H and Z represents the piperidinyl group.
- X is selected from 0; N-R 'where R' is H or a C1-C6 alkyl group; and N-OR "wherein R" represents H, a C1-C6 alkyl group, or an aryl group;
- R 1 represents H or a C1-C6 alkyl group
- R 2 represents H, a C 1 -C 6 alkyl group, or an alkylaryl group
- Z is NR 8 R 9 , with R 8 and R 9 , which are the same or different, each represent together or together a C 1 -C 6 alkyl group or an alkylaryl group.
- a compound of formula (III) in which Y and Z respectively represent the group NR 8 R 9 and the group NR 1: L R 12 as defined previously.
- at least one of NR 8 R 9 and NR 1: L R 12 but more preferably both, represent the same piperidinyl group.
- the invention relates to the intermediate compound of formula (IV) in which X represents O, R 2 represents H and Z represents the piperidinyl group, R 1 being as defined above, namely H when the compound (II) is oxaloacetic acid or a C1-C6 alkyl group when the compound (II) is the corresponding ester of oxaloacetic acid.
- the compound (II) is advantageously chosen from oxaloacetic acid and pyruvic acid.
- the process of the invention makes it possible to obtain different analogs of methionine.
- 2-oxo-4-methylthiobutanoic acid (KMB) or one of its salts, such as its calcium, magnesium, manganese, copper, zinc, sodium or ammonium salts and its corresponding selenium or one of its salts are products of the process of the invention under economically interesting conditions and yields.
- Another subject of the invention is a process of D, L-methionine, D- or L-methionine, D, L-2-hydroxy-4-methylthiobutanoic acid (HMTBA), or D- or L- -HMTBA, starting from 2-oxo-4-methylthiobutanoic acid (KMB), said process comprising the preparation of KMB according to the process of the invention as defined above and then converting the KMB thus obtained into methionine or HMTBA, chemically or biologically, by techniques known to those skilled in the art.
- HMTBA 2-oxo-4-methylthiobutanoic acid
- reaction medium is cooled to 10 ° C. and then the MeSH is added by bubbling into the reaction medium at 10 ° C. until the required amount (1 eq). The addition is completed in 4 hours then the set temperature is raised to 20 ° C. The reaction medium is stirred for 3h this temperature.
- a GC-FID control (column Equity-1) indicates that the conversion of piperidine is complete and the RRdose in species "thiomethyl activated" is 97%.
- reaction medium is withdrawn and then concentrated under reduced pressure (1mbar, 20 ° C., 6 h).
- KM B piperidinium is obtained as a yellow oil without further purification.
- Step 2 Condensation with pyruvic acid 0 2 C .piperidinium
- reaction medium is cooled to 20 ° C. and the solvent is then evaporated under reduced pressure (10 °, 20 ° C., 1 h) to give (IV) as a pale yellow oil (1.2 g).
- the MeSH gas is introduced in Iesel (via a syringe pump).
- the reaction medium is then heated to 60 ° C in 1 hour and then this temperature is maintained for 30 minutes.
- HPLC control indicates a complete transformation of the intermediate and the majority formation of KM B piperidinium.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1650366A FR3046791B1 (fr) | 2016-01-18 | 2016-01-18 | Procede de preparation d'analogues de la methionine |
| PCT/FR2017/050096 WO2017125673A1 (fr) | 2016-01-18 | 2017-01-17 | Procédé de préparation d'analogues de la méthionine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3405452A1 true EP3405452A1 (de) | 2018-11-28 |
Family
ID=56263788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17706536.4A Withdrawn EP3405452A1 (de) | 2016-01-18 | 2017-01-17 | Verfahren zur herstellung von methioninanaloga |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200283387A1 (de) |
| EP (1) | EP3405452A1 (de) |
| JP (1) | JP2019503380A (de) |
| KR (1) | KR20180101481A (de) |
| CN (1) | CN108779064A (de) |
| AR (1) | AR107581A1 (de) |
| BR (1) | BR112018014391A2 (de) |
| FR (1) | FR3046791B1 (de) |
| RU (1) | RU2736212C2 (de) |
| SG (1) | SG11201806119VA (de) |
| TW (1) | TW201726613A (de) |
| WO (1) | WO2017125673A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113845454A (zh) * | 2020-06-28 | 2021-12-28 | 张科春 | 一种酮基蛋氨酸及其衍生物的制备方法及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130996C (de) * | 1965-09-24 | |||
| DK649787A (da) * | 1986-12-23 | 1988-06-24 | Hoffmann La Roche | Fremgangsmaade til fremstilling af optisk aktive smoersyrederivater |
| US5731299A (en) * | 1992-05-29 | 1998-03-24 | The Procter & Gamble Company | Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| CN101921203A (zh) * | 2009-06-09 | 2010-12-22 | 长江大学 | N-苯氧苯基取代的α-氨基酸及其衍生物以及用作除草剂的用途 |
| CN102120742B (zh) * | 2010-01-08 | 2013-03-13 | 中国药科大学 | 一种丁苯那嗪的制备方法 |
| JP2012067073A (ja) * | 2010-08-27 | 2012-04-05 | Sumitomo Chemical Co Ltd | 含硫黄2−ケトカルボン酸化合物の製造方法 |
| JP2012126651A (ja) * | 2010-12-13 | 2012-07-05 | Sumitomo Chemical Co Ltd | ヒドロキシカルボン酸化合物またはその塩の製造方法 |
| JP2013075885A (ja) * | 2011-09-16 | 2013-04-25 | Sumitomo Chemical Co Ltd | メチオニンの製造方法 |
| TWI633089B (zh) * | 2013-03-28 | 2018-08-21 | 拜耳製藥股份有限公司 | 經取代的酮基吡啶衍生物 |
-
2016
- 2016-01-18 FR FR1650366A patent/FR3046791B1/fr not_active Expired - Fee Related
-
2017
- 2017-01-17 EP EP17706536.4A patent/EP3405452A1/de not_active Withdrawn
- 2017-01-17 CN CN201780007108.5A patent/CN108779064A/zh active Pending
- 2017-01-17 SG SG11201806119VA patent/SG11201806119VA/en unknown
- 2017-01-17 RU RU2018126611A patent/RU2736212C2/ru active
- 2017-01-17 TW TW106101513A patent/TW201726613A/zh unknown
- 2017-01-17 KR KR1020187022821A patent/KR20180101481A/ko not_active Withdrawn
- 2017-01-17 AR ARP170100122A patent/AR107581A1/es unknown
- 2017-01-17 US US16/070,762 patent/US20200283387A1/en not_active Abandoned
- 2017-01-17 JP JP2018537471A patent/JP2019503380A/ja not_active Ceased
- 2017-01-17 WO PCT/FR2017/050096 patent/WO2017125673A1/fr not_active Ceased
- 2017-01-17 BR BR112018014391-0A patent/BR112018014391A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018126611A3 (de) | 2020-02-28 |
| RU2736212C2 (ru) | 2020-11-12 |
| WO2017125673A1 (fr) | 2017-07-27 |
| US20200283387A1 (en) | 2020-09-10 |
| KR20180101481A (ko) | 2018-09-12 |
| FR3046791A1 (fr) | 2017-07-21 |
| FR3046791B1 (fr) | 2020-01-10 |
| SG11201806119VA (en) | 2018-08-30 |
| JP2019503380A (ja) | 2019-02-07 |
| BR112018014391A2 (pt) | 2018-12-11 |
| RU2018126611A (ru) | 2020-02-20 |
| AR107581A1 (es) | 2018-05-16 |
| CN108779064A (zh) | 2018-11-09 |
| TW201726613A (zh) | 2017-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2627645B1 (de) | Verfahren zur herstellung von 2-hydroxybutyrolacton | |
| FR2933693A1 (fr) | Procede de separation d'un acide carboxylique sous forme salifiee porteur d'au moins un atome d'halogene | |
| WO2009092912A1 (fr) | Procede de preparation de composes morphiniques | |
| AU2018205146A1 (en) | Process for the preparation of a polyunsaturated ketone compound | |
| EP0729936A1 (de) | Verfahren zur Synthese der alpha-substiuierten Akrylsäuren und deren Verwendung | |
| WO2015011206A1 (en) | Process for the preparation of a polyunsaturated ketone compound | |
| FR2558837A1 (fr) | Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant | |
| EP3405452A1 (de) | Verfahren zur herstellung von methioninanaloga | |
| FR2791673A1 (fr) | Procede de preparation des esters de l'acide hydroxymethylthiobutyrique | |
| EP0030528B1 (de) | Verfahren zur Einführung von Alkyl-Aralkyl-Cycloalkylgruppen in eine Funktionsgruppe enthaltende Kohlenstoffkette | |
| EP0171320A1 (de) | Herstellungsverfahren von ungesättigten, in alpha-chlorierten Verbindungen von zwei in beta-Stellung elektronenanziehenden Gruppen | |
| WO2002006209A1 (fr) | Procede de synthese de la n1, n3-bis (2-aminoethyl)propane-1,3-diamine, intermediaires de synthese, produits ainsi obtenus et leur application a la synthese de cyclam | |
| EP3233779B1 (de) | Neuartiges verfahren zur herstellung von synthesezwischenprodukten unter verwendung von produkten natürlichen ursprungs und verwendung der gewonnenen zwischenprodukte | |
| EP3280704B1 (de) | Verfahren zur synthese eines vorläufers eines einzigen milch-lacton-isomers | |
| EP0466583B1 (de) | Verfahren zur Herstellung von 2,5-Dimethyl-4-hydroxy-3(2H)-furanon | |
| WO2023031552A1 (fr) | Procede de fabrication de l'anion pentazolate a l'aide d'un oxydant a l'iode hypervalent | |
| EP4341214A1 (de) | Verfahren zur herstellung von ammoniakstickstoff | |
| CA2031249A1 (fr) | Procede de preparation d'halogenoacetals a partir d'enamines | |
| FR3055627A1 (fr) | Methode de preparation du compose cdb-3877 | |
| BE837804A (fr) | Derives de thiophene ou de furanne et procede pour leur preparation | |
| FR2931479A1 (fr) | Nouveaux derives de quinoleines 2-substituees et un procede pour leur preparation | |
| FR2632642A1 (fr) | Nouveaux derives dioxaniques pouvant etre optiquement actifs, leur procede de preparation et applications | |
| FR2795070A1 (fr) | Nouveaux composes de type diamine mono- ou poly- fluore, sulfonyle ou carbonyle, leur procede de preparation et leur application en catalyse asymetrique | |
| FR2805258A1 (fr) | Procede pour fabriquer du perfluoroalcanesulfinate | |
| BE862629A (fr) | Nouveaux derives de substitution de la n-hexahydro-s-triazine et procede de preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20180814 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MONBRUN, JEROME Inventor name: HUET, ROBERT Inventor name: AIRIAU, ETIENNE Inventor name: HENRYON, VIVIEN Inventor name: REY, PATRICK Inventor name: AUBRY, SYLVAIN |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20201214 |
|
| GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| INTC | Intention to grant announced (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20210126 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20210331 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20210811 |